EANS-Voting Rights: Marinomed Biotech AG
Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act
-------------------------------------------------------------------------------- Notification of voting rights transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement. -------------------------------------------------------------------------------- Overview 1. Issuer: Marinomed Biotech AG 2. Reason for the notification: Acquisition or disposal of voting rights 3. Person subject to notification obligation Acting in concert (Sec. 133 No. 7 BörseG 2018) ____________________________________________________________________________ | First name | Name/Surname | City | Country | |_________________|_____________________|_____________________|______________| |Abdulmohsen |Al Sheikh | | | |_________________|_____________________|_____________________|______________| |Mohammed |Al Sheikh | | | |_________________|_____________________|_____________________|______________| | |Acropora Beteiligungs| | | | |GmbH |Vienna |Austria | |_________________|_____________________|_____________________|______________| 4. Name of shareholder(s): 5. Date on which the threshold was crossed or reached: 22.1.2020 6. Total positions: ______________________________________________________________________________ | | | % of voting | | | | | |rights through | | | | | % of voting |financial/other|Total of both|Total number of | | |rights attached| instruments |in % (7.A + |voting rights of| | |to shares (7.A)|(7.B.1 + 7.B.2)|7.B) | issuer | |_______________|_______________|_______________|_____________|________________| |Resulting | | | | | |situation on | | | | | |the date on | | | | | |which threshold| 16.59 % | 0,00 % | 16.59 % |1,469,772 | |was crossed / | | | | | |reached | | | | | |_______________|_______________|_______________|_____________|________________| |Position of | | | | | |previous | | | | | |notification | 23.27 % | 0,00 % | 23.27 % | | |(if applicable)| | | | | |_______________|_______________|_______________|_____________|________________| Details 7. Notified details of the resulting situation: ______________________________________________________________________________ |A: Voting rights attached to shares | |______________________________________________________________________________| | |Number of voting rights |% of voting rights | | |_______________________________|_________________________________| | | Direct |Indirect (Sec | Direct |Indirect (Sec | |ISIN Code |(Sec 130 BörseG|133 BörseG |(Sec 130 BörseG |133 BörseG | | | 2018) |2018) | 2018) |2018) | |____________|_______________|_______________|________________|________________| |AT0000831706| 243,860| | 16.59 %| | |____________|_______________|_______________|________________|________________| |SUBTOTAL A | 243,860| 16.59%| |____________|_______________________________|_________________________________| __________________________________________________________________________ |B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 | |BörseG 2018 | |__________________________________________________________________________| | | | |Number of voting | | | | | | rights that may | | |Type of | | | be acquired if |% of voting| |instrument|Expiration Date| Exercise Period|the instrument is|rights | | | | | exercised | | |__________|_______________|_________________|_________________|___________| |__________|_______________|_________________|_________________|___________| | | SUBTOTAL B.1| | | |__________________________|_________________|_________________|___________| ________________________________________________________________________ |B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 | |BörseG 2018 | |________________________________________________________________________| | |Expiration|Exercise|Physical / Cash|Number of |% of voting| |Type of |Date |Period |Settlement |voting rights|rights | |instrument|__________|________|_______________|_____________|___________| |__________|__________|________|_______________|_____________|___________| | | SUBTOTAL B.2 | | | |______________________________|_______________|_____________|___________| 8. Information in relation to the person subject to the notification obligation: Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity: _____________________________________________________________________________ | | | | |Financial/ | | | | | Directly | |other | | | | |controlled | Shares held |instruments |Total of both| | No. | Name | by No. |directly (%) |held directly| (%) | | | | | | (%) | | |__________|____________|___________|_____________|_____________|_____________| | |Abdulmohsen | | | | | | 1 |Al Sheikh | | | | | |__________|____________|___________|_____________|_____________|_____________| | |Mohammed Al | | | | | | 2 |Sheikh | | | | | |__________|____________|___________|_____________|_____________|_____________| | |Acropora | | | | | | 3 |Beteiligungs| 1,2 | 16.59 %| | 16.59 %| | |GmbH | | | | | |__________|____________|___________|_____________|_____________|_____________| 9. In case of proxy voting Date of general meeting: - Voting rights after general meeting: - is equivalent to - voting rights. 10. Additional comments: The disclosure obligation arose because the number of shares held dropped below the threshold due to the sale of 73,500 shares. Further inquiry note: Dr. Eva Prieschl-Grassauer Chief Scientific Officer, Marinomed Veterinärplatz 1, 1210 Vienna, Austria T +43 (0)1 250 77 4460 E-Mail: eva.prieschl@marinomed.com http://www.marinomed.com Roland Mayrl Managing Partner, Metrum Communications Bauernmarkt 10/19, 1010 Vienna, Austria T +43 (0) 1 504 69 87 331 E-Mail: r.mayrl@metrum.at http://www.metrum.at end of announcement euro adhoc --------------------------------------------------------------------------------
issuer: Marinomed Biotech AG
Veterinärplatz 1
A-1210 Wien
phone: 0043250774460
FAX: 0043250774493
mail: office@marinomed.com
WWW: www.marinomed.com
ISIN: ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language: English
Original-Content von: Marinomed Biotech AG, übermittelt durch news aktuell